Zepbound (tirzepatide) is a dual GLP-1/GIP receptor agonist primarily approved for chronic weight management, and also for type 2 diabetes (as Mounjaro), working by enhancing insulin secretion, slowing gastric emptying, and reducing appetite
At the same time, the findings for clinical studies were more mixed, and long-term trials showed the possibility of a lower dementia risk with these drugs, but shorter trials did not show consistent cognitive improvements
Regularly Challengeand FeedYour Muscles Taking a GLP-1 doesnt mean you can skip the gym
And none of them were working for very long
By supporting acetylcholine levels, ALCAR may help improve vagal tone, thereby understanding the mechanisms of dysautonomia and providing a stabilizing effect on the autonomic nervous system